Cosinuss° in-ear mobile monitoring of vital signs

#1 GROUP PROСUREMENT ORGANIZATION (GPO)

Medtech

Cosinuss° in-ear mobile monitoring of vital signs

Electronics

Smart mirror that identifies serious illnesses

Medtech

The CardiacSense: reliable cardiac and blood pressure monitoring

ifeel research-based Biosense Gaming for Improved Breathing

iFeel Labs award-winning apps guide you to discover the benefits of a specialized technique to optimize breathing by playing fun games. The mobile apps include popular games (like Candy Crush) which have been converted to even more engaging biosense games. The apps precisely guide your inhale and exhale to maximize the proven benefits of Heart Rate Variability (HRV) breathing. You only progress in the game when you are breathing properly and healthily. With iFeel Labs optimal breathing solution, a healthier future is already here.

 

by
2024.02.29

Owlet can track Baby's Heart Rate and Oxygen Levels

Owlet Baby Care is a health technology company. The company’s flagship product is the Smart Sock Baby Monitor, which uses pulse oximetry technology to track such biomarkers as a baby’s heart rate and oxygen levels during sleep. Owlet’s mission is to empower parents with the right information at the right time. The Smart Sock comfortably wraps around baby’s foot to track heart rate, oxygen levels and sleep. The base station glows green to let know everything is okay but notifies with lights and sounds if heart rate or oxygen levels leave preset zones. Parents can see live readings using Owlet’s app but can also use trended sleep data and historical heart and oxygen information using the Connected Care app to improve their baby’s overall wellness.

by
2024.02.29

Mobile platform that analyzes the human body and its full body metrics in 3D

Nettelo 3D Body Scan enables consumers to obtain an accurate 3D digital model of their body with a smartphone and provides businesses with both user’s body metrical analysis medical information and product matching solutions. The researchers intend to democratize human 3D body scanning and analysis through their patent-pending mobile technology and cloud services. This will unlock high-value opportunities for consumers and businesses across a broad range of markets, including fashion and apparel, lifestyle, fitness and weight management, medical and sports clothes and special wearables.

by
2024.02.29
Electronics

Sound-based touch input technology for smart tables and mirrors

Wellness

FUSION GENOMICS: a new era in pathogen sequencing

Pharma

Erythra: a simple solution to difficult problems

Everwell: a user-centric technology for healthcare programs

Everwell Health Solutions is a Bangalore-based company that innovates, designs, builds and deploys user-centric technology for healthcare programs across the world. The company spun out of Microsoft Research India in 2015 by co-founders Andrew Cross and Bill Thies. Joined by Nakull Gupta, they began building a team in 2016 to champion their flagship work in digital adherence monitoring, 99DOTS, out of research and into large scale uptake in India. The company’s Everwell Hub is a comprehensive, integrated platform for adherence and patient management. Health care staff can log into a single portal to register and follow up with patients, whose adherence reports from any of its integrated technologies appear side-by-side including 99DOTS, evriMED devices, and VOT.

by
2024.02.29

Pioneering AI-based cancer diagnostics in pathology

Ibex Medical Analytics was conceived when its two founders were looking for ways to apply their skills to contribute to human well-being. They were captivated with the opportunity presented by applying artificial intelligence (AI) to medicine and, in particular, the potential it holds for advancing cancer care. They decided to combine their accumulated knowledge of AI, data science, image analysis and machine learning, and apply it to cancer diagnostics in pathology. Today, Ibex is a multidisciplinary team comprising entrepreneurs, data scientists, software engineers and medical experts, working together to realize vision: Applying AI to cancer diagnostics, striving to improve patient outcomes and quality of life.

by
2024.02.29

XEPTAGEN provides diagnostic solutions

XEPTAGEN SpA is engaged in the discovery and validation of novel molecular markers in order to produce innovative diagnostic kits for cancer (lat. Carcinoma) early detection, monitoring, and evaluation of response to therapy. By exploiting the natural immune response to early-stage cancer and the proprietary platform technology Combinatorial Proteomic®, XEPTAGEN has discovered predictive, prognostic and early response tumour markers that lead to earlier and much more accurate detection of developing carcinomas. The company's mission is to include creating innovative tools that improve the clinical management of patients with liver, colorectal and prostate cancers (lat. Prostate Carcinoma).

by
2024.02.29

Cookies help us deliver our Services. By using our website or clicking I agree, you agree to our use of cookies. Learn more about our cookie and privacy policy.

I AGREE

#1 GROUP PROСUREMENT ORGANISATION (GPO) 

  • Focus on Biotech Brands
  • Purchasing volume €368 mln/year
  • 75 Countries
  • 100% distribution exclusivity